Therapeutic combinations and compositions for the treatment of inflammatory bowel disease

G. Dijkstra; Klaas Nico Faber; Hermanus Jozef Martinus Harmsen; Robert Steinert; Wilbert Sybesma; Araksya Topchyan

Therapeutic combinations and compositions for the treatment of inflammatory bowel disease

G. Dijkstra (Inventor), Klaas Nico Faber (Inventor), Hermanus Jozef Martinus Harmsen (Inventor), Robert Steinert (Inventor), Wilbert Sybesma (Inventor), Araksya Topchyan (Inventor)

Research output: Patent

16 Downloads (Pure)

Abstract

The present invention relates to pharmaceutical combinations of at least one thiopurine and/or at least a pharmaceutically acceptable salt and/or at least one prodrug thereof and riboflavin to treat patients suffering from inflammatory bowel disease (IBD) or other inflammatory conditions. This invention also relates to additive and/or combinations of at least one thiopurine and riboflavin. This invention is also related to a method for the treatment or prophylaxis of IBD or other inflammatory conditions, which method comprises administering a therapeutically effective amount of thiopurine and riboflavin.

Original language	English
Patent number	WO2020161088
Priority date	04/02/2019
Filing date	04/02/2020
Publication status	Published - 13-Aug-2020

Access to Document

WO2020161088_A1Final publisher's version, 1.91 MB

Cite this

@misc{bba88ed2836245d3b62d4b368f781705,

title = "Therapeutic combinations and compositions for the treatment of inflammatory bowel disease",

abstract = "The present invention relates to pharmaceutical combinations of at least one thiopurine and/or at least a pharmaceutically acceptable salt and/or at least one prodrug thereof and riboflavin to treat patients suffering from inflammatory bowel disease (IBD) or other inflammatory conditions. This invention also relates to additive and/or combinations of at least one thiopurine and riboflavin. This invention is also related to a method for the treatment or prophylaxis of IBD or other inflammatory conditions, which method comprises administering a therapeutically effective amount of thiopurine and riboflavin.",

author = "G. Dijkstra and Faber, {Klaas Nico} and Harmsen, {Hermanus Jozef Martinus} and Robert Steinert and Wilbert Sybesma and Araksya Topchyan",

year = "2020",

month = aug,

day = "13",

language = "English",

type = "Patent",

note = "WO2020161088",

}

TY - PAT

T1 - Therapeutic combinations and compositions for the treatment of inflammatory bowel disease

AU - Dijkstra, G.

AU - Faber, Klaas Nico

AU - Harmsen, Hermanus Jozef Martinus

AU - Steinert, Robert

AU - Sybesma, Wilbert

AU - Topchyan, Araksya

PY - 2020/8/13

Y1 - 2020/8/13

N2 - The present invention relates to pharmaceutical combinations of at least one thiopurine and/or at least a pharmaceutically acceptable salt and/or at least one prodrug thereof and riboflavin to treat patients suffering from inflammatory bowel disease (IBD) or other inflammatory conditions. This invention also relates to additive and/or combinations of at least one thiopurine and riboflavin. This invention is also related to a method for the treatment or prophylaxis of IBD or other inflammatory conditions, which method comprises administering a therapeutically effective amount of thiopurine and riboflavin.

AB - The present invention relates to pharmaceutical combinations of at least one thiopurine and/or at least a pharmaceutically acceptable salt and/or at least one prodrug thereof and riboflavin to treat patients suffering from inflammatory bowel disease (IBD) or other inflammatory conditions. This invention also relates to additive and/or combinations of at least one thiopurine and riboflavin. This invention is also related to a method for the treatment or prophylaxis of IBD or other inflammatory conditions, which method comprises administering a therapeutically effective amount of thiopurine and riboflavin.

M3 - Patent

M1 - WO2020161088

Y2 - 2020/02/04

ER -